Concepedia

Madhavi Tadi

MT

10

Publications

3.2K

Citations

10

H-Index

2006

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

University of Miami

Sylvester Comprehensive Cancer Center

Harvard University

Madhavi Tadi is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and signal transduction.

Top concepts

Publications per year

2006–2018

10

Publications

10

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

Poulikos I. Poulikakos, Yogindra Persaud, Manickam Janakiraman et al. · Nature · 2011 · 1.4K citations

, , +1

Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas

Piro Lito, Christine A. Pratilas, Eric W. Joseph et al. · Cancer Cell · 2012 · 551 citations · Full text

, , +11

The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner

Eric W. Joseph, Christine A. Pratilas, Poulikos I. Poulikakos et al. · Proceedings of the National Academy of Sciences · 2010 · 446 citations · Full text

Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors

Dalia Ercan, Chunxiao Xu, Masahiko Yanagita et al. · Cancer Discovery · 2012 · 290 citations · Full text

Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis

Fan Liu, Guoyan Cheng, Pierre-Jacques Hamard et al. · Journal of Clinical Investigation · 2015 · 148 citations · Full text

, , +18

Rows per page

1–5 of 10